Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Roche lifts 2024 profit guidance on strong drug sales
Roche lifts 2024 profit guidance on strong drug sales
Roche lifts 2024 profit guidance on strong drug sales
Submitted by
admin
on July 25, 2024 - 11:27am
Source:
Reuters
News Tags:
Roche
earnings
Vabysmo
Headline:
Roche lifts 2024 profit guidance on strong drug sales
snippet:
First-half operating profit growth beats analyst estimates
Revenue from eye drug Vabysmo nearly doubles, beats estimates
Expects close to 10% adjusted profit growth, up vs previous
Shares traded near 1-year high earlier on Thursday
Do Not Allow Advertisers to Use My Personal information
